Cyclo-oxygenase-2 Inhibitors and the Kidney: a Case for Caution

Overview

Journal Drug Saf

Specialties Pharmacology
Toxicology

Date 2002 Apr 12

PMID 11945113

Citations 6

Authors

Gary Noroian

David Clive

Affiliations

Soon will be listed here.

Abstract

Cyclo-oxygenase (COX) is one of the key enzymes in the biosynthesis of prostaglandins. Two isoforms of this enzyme COX-1 and COX-2 are known to exist. Among other functions, prostaglandins play an important role in the protection of the gastric mucosa and maintenance of renal function in pathophysiological conditions which would otherwise threaten it. Conventional nonsteroidal anti-inflammatory drugs (NSAIDs) block prostaglandin synthesis, resulting in gastric mucosal injury and renal dysfunction in susceptible individuals. The recent introduction of selective COX-2 inhibitors, celecoxib and rofecoxib, appear to induce less gastrointestinal morbidity. Although conclusive data are still lacking, there is evidence to suggest that COX-2 antagonists may be capable of causing some of the same renal syndromes seen in association with the older, less selective NSAIDs.

Citing Articles

Attitude and Awareness of Dentists Practicing in Southern India Toward Non-steroidal Anti-inflammatory Drugs.

Monisha M, Elengickal T, Ram S, Madhu M, Raghuveeran M, Pillai R J Pharm Bioallied Sci. 2019; 11(Suppl 2):S355-S359.

PMID: 31198368 PMC: 6555374. DOI: 10.4103/JPBS.JPBS_33_19.

Nonsteroidal Anti-Inflammatory Drugs and the Kidney.

Horl W Pharmaceuticals (Basel). 2016; 3(7):2291-2321.

PMID: 27713354 PMC: 4036662. DOI: 10.3390/ph3072291.

COX-2 inhibitors: a CLASS act or Just VIGORously promoted.

Malhotra S, Shafiq N, Pandhi P MedGenMed. 2004; 6(1):6.

PMID: 15208519 PMC: 1140734.

Effects of NSAIDs on the incidence of hospitalisations for renal dysfunction in users of ACE inhibitors.

Bouvy M, Heerdink E, Hoes A, Leufkens H Drug Saf. 2003; 26(13):983-9.

PMID: 14583072 DOI: 10.2165/00002018-200326130-00006.

Valdecoxib.

Ormrod D, Wellington K, Wagstaff A Drugs. 2002; 62(14):2059-71; discussion 2072-3.

PMID: 12269850 DOI: 10.2165/00003495-200262140-00005.

References

Harding P, Sigmon D, Alfie M, Huang P, Fishman M, BEIERWALTES W . Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet. Hypertension. 1997; 29(1 Pt 2):297-302. DOI: 10.1161/01.hyp.29.1.297. View

Bevis P, Bird H, Lapham G . An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment. Br J Rheumatol. 1996; 35 Suppl 1:56-60. DOI: 10.1093/rheumatology/35.suppl_1.56. View

Harding P, Carretero O, BEIERWALTES W . Chronic cyclooxygenase-2 inhibition blunts low sodium-stimulated renin without changing renal haemodynamics. J Hypertens. 2000; 18(8):1107-13. DOI: 10.1097/00004872-200018080-00016. View

Gross J, Dwyer J, KNOX F . Natriuretic response to increased pressure is preserved with COX-2 inhibitors. Hypertension. 1999; 34(5):1163-7. DOI: 10.1161/01.hyp.34.5.1163. View

Stillman M, Napier J, Blackshear J . Adverse effects of nonsteroidal anti-inflammatory drugs on the kidney. Med Clin North Am. 1984; 68(2):371-85. DOI: 10.1016/s0025-7125(16)31136-1. View

Silverstein F, Faich G, Goldstein J, Simon L, Pincus T, WHELTON A . Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA. 2000; 284(10):1247-55. DOI: 10.1001/jama.284.10.1247. View

Dunn M . Nonsteroidal antiinflammatory drugs and renal function. Annu Rev Med. 1984; 35:411-28. DOI: 10.1146/annurev.me.35.020184.002211. View

Ichitani Y, Holmberg K, MAUNSBACH A, Haeggstrom J, Samuelsson B, De Witt D . Cyclooxygenase-1 and cyclooxygenase-2 expression in rat kidney and adrenal gland after stimulation with systemic lipopolysaccharide: in situ hybridization and immunocytochemical studies. Cell Tissue Res. 2001; 303(2):235-52. DOI: 10.1007/s004410000296. View

Norwood V, Morham S, SMITHIES O . Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice. Kidney Int. 2000; 58(6):2291-300. DOI: 10.1046/j.1523-1755.2000.00413.x. View

10.

Perazella M, Eras J . Are selective COX-2 inhibitors nephrotoxic?. Am J Kidney Dis. 2000; 35(5):937-40. DOI: 10.1016/s0272-6386(00)70266-6. View

11.

Yang T, Singh I, Pham H, Sun D, Smart A, Schnermann J . Regulation of cyclooxygenase expression in the kidney by dietary salt intake. Am J Physiol. 1998; 274(3):F481-9. DOI: 10.1152/ajprenal.1998.274.3.F481. View

12.

Wang J, Cheng H, Harris R . Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension. Hypertension. 1999; 34(1):96-101. DOI: 10.1161/01.hyp.34.1.96. View

13.

Zimran A, Kramer M, Plaskin M, Hershko C . Incidence of hyperkalaemia induced by indomethacin in a hospital population. Br Med J (Clin Res Ed). 1985; 291(6488):107-8. PMC: 1416244. DOI: 10.1136/bmj.291.6488.107. View

14.

Abassi Z, Brodsky S, Gealekman O, Rubinstein I, Hoffman A, Winaver J . Intrarenal expression and distribution of cyclooxygenase isoforms in rats with experimental heart failure. Am J Physiol Renal Physiol. 2001; 280(1):F43-53. DOI: 10.1152/ajprenal.2001.280.1.F43. View

15.

Swan S, Rudy D, Lasseter K, Ryan C, Buechel K, Lambrecht L . Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial. Ann Intern Med. 2000; 133(1):1-9. DOI: 10.7326/0003-4819-133-1-200007040-00002. View

16.

Cheng H, Wang J, Zhang M, Wang S, McKanna J, Harris R . Genetic deletion of COX-2 prevents increased renin expression in response to ACE inhibition. Am J Physiol Renal Physiol. 2001; 280(3):F449-56. DOI: 10.1152/ajprenal.2001.280.3.F449. View

17.

Blume C, Heise G, Muhlfeld A, Bach D, Schror K, Gerhardz C . Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat. Kidney Int. 1999; 56(5):1770-8. DOI: 10.1046/j.1523-1755.1999.00742.x. View

18.

Bosch-Marce M, Claria J, Titos E, Masferrer J, Altuna R, Poo J . Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites. Gastroenterology. 1999; 116(5):1167-75. DOI: 10.1016/s0016-5085(99)70020-x. View

19.

Palmer B . Renal complications associated with use of nonsteroidal anti-inflammatory agents. J Investig Med. 1995; 43(6):516-33. View

20.

Rodriguez F, Llinas M, Gonzalez J, Rivera J, Salazar F . Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake. Hypertension. 2000; 36(2):276-81. DOI: 10.1161/01.hyp.36.2.276. View